Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia

Alvin Wei Tian Ng(Duke-NUS Medical School), Steve Rozen(Duke University), Alex Y. Chang(Cornell University), Po‐Huang Lee(E-Da Hospital), Bin Tean Teh(Agency for Science, Technology and Research), Jing Quan Lim(National Cancer Centre Singapore), Arnoud Boot(Baylor College of Medicine), Sen‐Yung Hsieh(Chang Gung University of Science and Technology), Song Ling Poon(International Life Sciences Institute India), Ming‐Chin Yu, Willie Yu(Singapore Eye Research Institute), Mi Ni Huang(Duke-NUS Medical School), Saranya Thangaraju(National Cancer Centre Singapore), Yuka Suzuki(Duke-NUS Medical School), Hao-Yi Huang(Chang Gung Memorial Hospital), Patrick Tan(SingHealth), See-Tong Pang(Chang Gung University), Cedric Chuan Young Ng
Science Translational Medicine
October 18, 2017
10.1126/scitranslmed.aan6446
Cited by 381

Related Papers

The repertoire of mutational signatures in human cancer
|Nature|2020|3.8k
Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome
|Science|1998|2.2k
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
|The Lancet|2005|2.1k
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
|Nature|2011|1.3k
Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2006|705